insights_auto
Why is COO down 2.40%?
Dive Deeperchevron_right
COO:NASDAQ
Cooper Companies Inc
$58.88
arrow_downward
-2.40%(-1.45) 1D
$59.53
arrow_upward
+1.10% (+0.65)bedtimeAfter hours
Closed: Nov 20, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COO...
Open
$60.66
High
$60.98
Low
$58.66
Mkt. cap
11.20B
Avg. vol.
2.63M
Volume
2.08M
P/E ratio
20.09
52-wk high
$89.83
52-wk low
$51.01
EPS
$2.93
Beta
0.83
Shares outstanding
190.16M
No. of employees
15K
Open
$60.66
High
$60.98
Low
$58.66
Mkt. cap
11.20B
Avg. vol.
2.63M
Volume
2.08M
P/E ratio
20.09
52-wk high
$89.83
52-wk low
$51.01
EPS
$2.93
Beta
0.83
Shares outstanding
190.16M
No. of employees
15K
News stories
From web sources and news partners
TradingView
·
59 minutes ago
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
Profile
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market. Wikipedia
About Cooper Companies Inc
CEOAlbert G. White III
Employees15K
Founded1958
HeadquartersPleasanton, California, United States
SectorHealth Care
IndustryMedical device
Websitecoopercos.com
Analyst ratings
Based on 14 analysts giving stock ratings to COO in the past 3 months
Buy
Buy
4
Hold
10
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for COO in the last 3 months.
Highest
Current $58.88
$75.00 (+27.38%)
Average
$64.83 (+10.11%)
Lowest
$58.00 (-1.49%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Christopher Pasquale Barclays | Hold | Maintained | $60.00 | +1.9% | 10/28/2026 |
Jason Bednar Piper Sandler | Hold | Maintained | $59.00 | +0.2% | 10/28/2026 |
Matt Miksic Barclays | Hold | Initiated | $60.00 | +1.9% | 10/06/2026 |
Joanne Wuensch Citi | Hold | Maintained | $60.00 | +1.9% | 10/02/2026 |
Jonathan Block Stifel Nicolaus | Buy | Maintained | $70.00 | +18.9% | 10/01/2026 |
Anthony Petrone Mizuho Securities | Buy | Maintained | $75.00 | +27.4% | 09/11/2026 |
Young Li Jefferies | Buy | Maintained | $70.00 | +18.9% | 09/10/2026 |
Steven Lichtman William Blair | Hold | Downgraded | - | - | 09/12/2026 |
Patrick Wood UBS | Hold | Reiterated | $66.00 | +12.1% | 09/10/2026 |
Robbie Marcus J.P. Morgan | Hold | Reiterated | $58.00 | -1.5% | 09/10/2026 |
David Saxon Needham | Buy | Maintained | $73.00 | +24% | 09/10/2026 |
Travis Steed Bank of America Securities | Hold | Downgraded | $65.00 | +10.4% | 09/10/2026 |
Larry Biegelsen Wells Fargo | Hold | Maintained | $61.00 | +3.6% | 09/09/2026 |
Jeff Johnson Robert W. Baird | Hold | Downgraded | $61.00 | +3.6% | 09/10/2026 |
Brett Fishbin KeyBanc | Hold | Maintained | - | - | 09/10/2026 |
Unknown Analyst UBS | Hold | Initiated | $75.00 | +27.4% | 07/28/2026 |
David Roman Goldman Sachs | Sell | Maintained | $61.00 | +3.6% | 05/27/2026 |
Unknown Analyst Wells Fargo | Hold | Reiterated | $82.00 | +39.3% | 05/22/2026 |
Issie Kirby Rothschild & Co Redburn | Hold | Downgraded | $85.00 | +44.4% | 03/04/2026 |
Next call in 12 days
Thu, Dec 3, 5:00 PM
Fiscal period
Q4 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $1.07
Revenue / Est. (USD)
- / 1.07B
Fiscal Q4 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 1.07B | 1.02B | 1.08B | 1.07B |
Cost of goods sold | 414.30M | 328.90M | 346.10M | 354.30M |
Cost of revenue | 414.30M | 328.90M | 346.10M | 354.30M |
Research and development expenses | 41.40M | 44.30M | 42.50M | 41.60M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 415.40M | 390.20M | 676.20M | 401.30M |
Operating expense | 506.60M | 482.40M | 766.40M | 489.90M |
Total operating expenses | 920.90M | 811.30M | 1.11B | 844.20M |
Operating income | 144.20M | 212.80M | -31.00M | 222.00M |
Other non operating income | -16.40M | 3.10M | 4.30M | 4.50M |
EBT including unusual items | 116.80M | 192.20M | -48.40M | 201.80M |
EBT excluding unusual items | 101.10M | 192.20M | -48.40M | 201.80M |
Income tax expense | 32.20M | 61.40M | 29.50M | -231.00M |
Effective tax rate | 27.57% | 31.95% | -60.95% | -114.47% |
Other operating expenses | - | - | - | - |
Net income | 84.60M | 130.80M | -77.90M | 432.80M |
Net profit margin | 7.94% | 12.77% | -7.20% | 40.59% |
Earnings per share | 1.15 | 1.10 | 1.21 | 1.15 |
Interest and investment income | - | - | - | - |
Interest expense | -24.40M | -22.40M | -20.90M | -21.50M |
Net interest expenses | -24.40M | -22.40M | -20.90M | -21.50M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 242.60M | 308.30M | 64.40M | 316.70M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events